Atherectomy Devices Market Regional Analysis

Skyquest Technology's expert advisors have carried out comprehensive global market analysis on the atherectomy devices market, covering regional industry trends and market insights. Our team of analysts have conducted in-depth primary and secondary research to provide regional industry analysis and forecast of atherectomy devices market across North America, South America, Europe, Asia, the Middle East, and Africa.

Atherectomy Devices Market Regional Insights

North America is projected to account for a dominant share of the global atherectomy devices market. High incidence of multiple cardiovascular disorders and growing number of atherectomy procedures in this region allow it to hold a dominant stance. Rapidly increasing geriatric population, rising popularity of minimally invasive surgeries, and approvals of novel atherectomy devices are also expected to contribute to this region's dominance. The United States is projected to spearhead sales of atherectomy devices in the North American region followed by Canada. High healthcare expenditure in this region will also favor atherectomy device sales.

Adoption of poor lifestyles and eating habits has led to an increased incidence of cardiovascular disorders in the Asia Pacific region making it the fastest-growing market for atherectomy device providers. Growing awareness regarding cardiovascular disorders and the rising availability of novel treatments for the same are projected to create new business scope for atherectomy device companies. India, China, and Japan are slated to be the most opportune markets for atherectomy device providers owing to growing senescent population in these countries.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Atherectomy Devices Market size was valued at USD 962.41 Million in 2023 and is poised to grow from USD 1040.37 Million in 2024 to USD 1939.96 Million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Developing affordable and advanced atherectomy devices will be the prime focus of new as well as established companies in the future. Atherectomy devices providers can also maximize their business scope by riding the wave of minimally invasive surgery popularity going forward. Investing in research and development will be an unmissable strategy for all atherectomy devices companies working in this market. Emerging countries will provide attractive growth opportunities for atherectomy devices suppliers in the long run. 'Medtronic Plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Cardiovascular Systems, Inc. (USA) ', 'Royal Philips (Netherlands) ', 'Avinger, Inc. (USA) ', 'Terumo Corporation (Japan) ', 'AngioDynamics, Inc. (USA) ', 'Braun Group (Germany) ', 'Abbott Laboratories (USA) ', 'B. Braun Melsungen AG (Germany) ', 'Biotronik SE & Co. KG (Germany) ', 'Biomerics (USA) ', 'Philips (Netherlands) ', 'Cook Medical, Inc. (USA) ', 'Cardinal Health, Inc. (USA) ', 'Rex Medical, L.P. (USA) ', 'W. L. Gore & Associates, Inc. (USA) ', 'Minnetronix, Inc. (USA) ', 'Merit Medical Systems, Inc. (USA) ', 'NexStep Medical (USA)'

An aging population is more at risk of suffering from cardiovascular complications such as arterial blockages. Atherectomy devices are crucial in helping treat these disorders and growing preference for minimally invasive atherectomy procedures among geriatric people will also bolster atherectomy devices market growth in the future.

Integration of Advanced Technologies: Atherectomy device manufacturers should focus on integrating advanced technologies such as artificial intelligence and machine learning to improve the capabilities of their offerings. Companies can deploy these advanced technologies in their development as well as deployment to maximize business scope in the future.

North America is projected to account for a dominant share of the global atherectomy devices market. High incidence of multiple cardiovascular disorders and growing number of atherectomy procedures in this region allow it to hold a dominant stance. Rapidly increasing geriatric population, rising popularity of minimally invasive surgeries, and approvals of novel atherectomy devices are also expected to contribute to this region's dominance. The United States is projected to spearhead sales of atherectomy devices in the North American region followed by Canada. High healthcare expenditure in this region will also favor atherectomy device sales.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Atherectomy Devices Market
Atherectomy Devices Market

Report ID: SQMIG35A2953

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE